Cleared Traditional

K091364 - DICOMPACS

K091364 is the FDA 510(k) clearance for DICOMPACS by Oehm Und Rehbein GmbH. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 217-day FDA review.

K091364 · Oehm Und Rehbein GmbH · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2009
Decision
217d
Days
Class 2
Risk

K091364 is an FDA 510(k) clearance for the DICOMPACS, MODEL 5.2, DICOMPACS DX-R, MODEL 1.4. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Oehm Und Rehbein GmbH (Great Neck, US). The FDA issued a Cleared decision on December 11, 2009 after a review of 217 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Oehm Und Rehbein GmbH devices

Submission Details

510(k) Number K091364 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 08, 2009
Decision Date December 11, 2009
Days to Decision 217 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
110d slower than avg
Panel avg: 107d · This submission: 217d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1056
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K091364.
STORM-BASE 2.0
K093603 · KARL STORZ Endoscopy-America, Inc. · Mar 2010
SYNGO.PET&CT ONCOLOGY
K093621 · Siemens Medical Solutions USA, Inc. · Feb 2010
PCR ELEVA 1.2
K093355 · Philips Medical Systems, Inc. · Jan 2010
DIGITAL LIGHTBOX
K093117 · Brainlab AG · Dec 2009
INNOVA VISION, MODEL S18751VN, INNOVA TRACKVISION, MODEL S18751VT, INNOVA EPVISION, MODEL S18751EP
K092639 · GE Medical Systems SCS · Dec 2009
INTEGRATED REGISTRATION
K093234 · GE Medical Systems SCS · Oct 2009